Light-activated nanoparticles for #neovascular eye disease. Learn more about the innovations from Boston Children's Kohane lab: ms.spr.ly/6014TDreQ #drugdelivery #eyedisease

Top pick of 2019 #4: Beyond #multidrugresistance: Leveraging rare variants with machine and statistical learning models in Mycobacterium #tuberculosis resistance prediction Read the full #openaccess paper from Dr Kohane lab here -> thelancet.com/journals/ebiom…

[Viewpoint] 'Keeping Nanomedicine on Target' "A principal purpose of targeting or triggering is to improve the active agents’ therapeutic indices by preferentially increasing their concentrations at the desired site of effect." Read it here --> acspubs.co/JMHI50DfPtn

Check out this exciting new Nano Letters paper from Kohane’s lab Boston Children's Harvard Medical School. Targeting Nanoparticles to Bioengineered Human Vascular Networks! pubs.acs.org/doi/10.1021/ac…

This week's #StaffSpotlight is Dr. Daniel Kohane, Vice Chair of Research for BCH- Anesthesiology, Critical Care & Pain Medicine. Swipe to learn more about Dr. Kohane and his interests. #WeAre BostonChildrens

"Sometimes you can achieve really big things by thinking really, really small." - nanotechnologist, Daniel Kohane #TEDMED

Daniel Kohane to speak at #CRSBoston: Treatment of otitis media by #transtympanic delivery of antibiotics ow.ly/UKSW304sPQI